Table 2

Scores on the Udvalg for Kliniske Undersogelser Side Effect Rating Scale and patient and physician assessments at baseline and after 6 and 12 wk of treatment with loxapine, n = 24

Side effect or assessment, timeMean score (and SD)RangeRepeated ANOVA p value
Total of all psychic symptoms
 Baseline5.50 (3.83)1–130.015*
 6 wk3.50 (3.56)0–12
 12 wk2.50 (3.23)0–12
Neurologic
 Baseline1.33 (1.74)0–70.21
 6 wk1.13 (1.39)0–4
 12 wk0.88 (1.03)0–4
Autonomic
 Baseline2.92 (3.74)0–140.057
 6 wk2.33 (2.06)0–8
 12 wk1.42 (1.44)0–5
Other
 Baseline2.13 (3.43)0–130.86
 6 wk1.96 (1.65)0–6
 12 wk2.33 (2.85)0–11
Patient assessment
 Baseline1.13 (0.61)0–20.85
 6 wk1.25 (0.68)0–3
 12 wk1.21 (0.88)0–3
Physician assessment
 Baseline1.29 (0.46)1–20.18
 6 wk1.25 (0.53)0–2
 12 wk1.00 (0.66)0–2

  • ↵* Significant, p < 0.05.